...
首页> 外文期刊>The British Journal of Nutrition >The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance
【24h】

The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance

机译:外源胆固醇和脂质调节剂对肠淀粉样β-丰度的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Dietary cholesterol may influence Alzheimer's disease risk, because it regulates the synthesis of amyloid-beta. It was recently demonstrated in enterocytes of wild-type mice that intracellular amyloid-beta expression is enhanced in response to a high-fat diet made up of SFA and cholesterol. Intestinally derived amyloid-beta may be associated with postprandial lipoproteins in response to dietary fats and could be a key regulator in chylomicron metabolism. The present study was designed to investigate the role of cholesterol in modulating amyloid-beta abundance in enterocytes. Wild-type mice were fed a low-fat diet supplemented with 2 % (w/w) cholesterol. The effects of cholesterol absorption inhibition and cholesterol biosynthesis inhibition utilising ezetimibe and atorvastatin, respectively, were also studied. Quantitative immunohistochemistry was utilised to determine enterocytic amyloid-beta homeostasis. We found that enterocytic amyloid-beta concentration was significantly attenuated in mice fed the 2% (w/w) cholesterol diet. However, blocking cholesterol absorption reversed the cholesterol-feeding effect. Consistent with a suppressive effect of cholesterol on enterocytic amyloid-beta abundance, atorvastatin, an inhibitor of cholesterol biosynthesis, enhanced amyloid-beta. However, providing exogenous cholesterol abolished the atorvastatin-induced effect. In contrast to the suppression of enterocytic amyloid-beta by dietary cholesterol, mice fed a diet enriched in SFA had markedly greater abundance. Collectively, the findings suggest that exogenous and endogenous cholesterol reduce amyloid-beta concentration in enterocytes by suppressing production, or enhancing secretion associated with postprandial lipoproteins. Intestinally derived amyloid-beta will contribute to the pool of plasma protein and may influence cerebral amyloid homeostasis by altering the bi-directional transfer across the blood-brain barrier.
机译:饮食中的胆固醇可能会影响阿尔茨海默氏病的风险,因为它调节淀粉样β的合成。最近证明,在野生型小鼠的肠上皮细胞中,响应由SFA和胆固醇组成的高脂饮食,细胞内淀粉样β的表达会增强。肠道来源的淀粉样蛋白-β可能与膳食脂肪相关,与餐后脂蛋白有关,并且可能是乳糜微粒代谢中的关键调节剂。本研究旨在研究胆固醇在调节肠上皮细胞淀粉样β丰度中的作用。野生型小鼠接受低脂饮食,其中补充了2%(w / w)胆固醇。还分别研究了依泽替米贝和阿托伐他汀对胆固醇吸收抑制和胆固醇生物合成抑制的作用。定量免疫组织化学用于确定肠淀粉样β动态平衡。我们发现饲喂2%(w / w)胆固醇饮食的小鼠的肠淀粉样β浓度显着降低。但是,阻断胆固醇的吸收会逆转胆固醇的喂养作用。与胆固醇对肠淀粉样β-丰度的抑制作用一致,胆固醇生物合成抑制剂阿托伐他汀可增强淀粉样β。但是,提供外源胆固醇消除了阿托伐他汀诱导的作用。与饮食胆固醇抑制肠淀粉样β的相反,饲喂富含SFA饮食的小鼠的丰度明显更高。总的来说,这些发现表明,外源性和内源性胆固醇通过抑制生产或增强与餐后脂蛋白相关的分泌,降低了肠细胞中淀粉样蛋白的浓度。肠道来源的淀粉样蛋白β将有助于血浆蛋白池,并可能通过改变跨血脑屏障的双向转移来影响大脑淀粉样蛋白的稳态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号